Literature DB >> 9307063

Intact proteins can bind to class II histocompatibility molecules with high affinity.

H A Runnels1, D A Weber, J C Moore, L E Westerman, P E Jensen.   

Abstract

The ability of intact protein antigens to bind to purified class II histocompatibility molecules was investigated. Intact bovine ribonuclease (RNase) inhibited peptide binding to DR1 with a potency similar to that of a high affinity peptide or irreversibly denatured RNase. Similarly, horse myoglobin (Mb) was a potent inhibitor of peptide binding to I-E(k). I-E(k)-Mb complexes were directly visualized as a distinct band with reduced mobility on SDS PAGE. Direct binding experiments with biotin-labeled proteins demonstrated that Mb and RNase bind to class II molecules through the peptide-binding groove with high affinity, and that binding occurs in the absence of detergent. The possibility that HLA-DM can catalyse the binding of intact protein antigens was supported by the observation that DM enhances the binding of biotin-RNase to DR1. Our results provide further support for the hypothesis that intact, partially unfolded protein antigens can act as ligands for initial interaction with class II molecules.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9307063     DOI: 10.1016/s0161-5890(97)00043-6

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  9 in total

Review 1.  Beyond the classical: influenza virus and the elucidation of alternative MHC class II-restricted antigen processing pathways.

Authors:  Laurence C Eisenlohr; Nancy Luckashenak; Sebastien Apcher; Michael A Miller; Gomathinayagam Sinnathamby
Journal:  Immunol Res       Date:  2011-12       Impact factor: 2.829

2.  The lymph as a pool of self-antigens.

Authors:  Cristina C Clement; Olaf Rotzschke; Laura Santambrogio
Journal:  Trends Immunol       Date:  2010-12-01       Impact factor: 16.687

3.  A short HLA-DRA isoform binds the HLA-DR2 heterodimer on the outer domain of the peptide-binding site.

Authors:  Hengameh Shams; Jill A Hollenbach; Atsuko Matsunaga; Mohammad R K Mofrad; Jorge R Oksenberg; Alessandro Didonna
Journal:  Arch Biochem Biophys       Date:  2022-02-24       Impact factor: 4.013

Review 4.  Conformational variation in structures of classical and non-classical MHCII proteins and functional implications.

Authors:  Corrie A Painter; Lawrence J Stern
Journal:  Immunol Rev       Date:  2012-11       Impact factor: 12.988

Review 5.  Partnering for the major histocompatibility complex class II and antigenic determinant requires flexibility and chaperons.

Authors:  Scheherazade Sadegh-Nasseri
Journal:  Curr Opin Immunol       Date:  2021-06-17       Impact factor: 7.268

6.  Divergent paths for the selection of immunodominant epitopes from distinct antigenic sources.

Authors:  AeRyon Kim; Isamu Z Hartman; Brad Poore; Tatiana Boronina; Robert N Cole; Nianbin Song; M Teresa Ciudad; Rachel R Caspi; Dolores Jaraquemada; Scheherazade Sadegh-Nasseri
Journal:  Nat Commun       Date:  2014-11-21       Impact factor: 14.919

7.  A splice acceptor variant in HLA-DRA affects the conformation and cellular localization of the class II DR alpha-chain.

Authors:  Alessandro Didonna; Vincent Damotte; Hengameh Shams; Atsuko Matsunaga; Stacy J Caillier; Ravi Dandekar; Maneesh K Misra; Mohammad R K Mofrad; Jorge R Oksenberg; Jill A Hollenbach
Journal:  Immunology       Date:  2020-10-19       Impact factor: 7.397

Review 8.  A step-by-step overview of the dynamic process of epitope selection by major histocompatibility complex class II for presentation to helper T cells.

Authors:  Scheherazade Sadegh-Nasseri
Journal:  F1000Res       Date:  2016-06-09

9.  HLA-DM catalytically enhances peptide dissociation by sensing peptide-MHC class II interactions throughout the peptide-binding cleft.

Authors:  Eduardo Reyes-Vargas; Adam P Barker; Zemin Zhou; Xiao He; Peter E Jensen
Journal:  J Biol Chem       Date:  2020-01-22       Impact factor: 5.157

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.